Sheel Biotech Limited (NSE:SHEEL)
India flag India · Delayed Price · Currency is INR
58.30
-2.70 (-4.43%)
At close: Nov 17, 2026

Sheel Biotech Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,3891,1001,018922.82801.16707.36
Revenue Growth
23.67%8.13%10.26%15.19%13.26%12.23%
Cost of Revenue
929.79694.32657.16576.22541.43478.27
Gross Profit
459.31405.9360.37346.6259.73229.09
Selling, General & Admin
177.12164.28151.99137.99106.3794.22
Other Operating Expenses
33.5432.8258.2663.2665.0270.17
Operating Expenses
221.1207.76219.26211.11181.56173.79
Operating Income
238.2198.14141.11135.4978.1755.3
Interest Expense
-16-14.69-14.46-11.5-11.17-9
Interest & Investment Income
2.532.530.780.760.573.01
Currency Exchange Gain (Loss)
0.740.740.471.060.170.29
Other Non Operating Income (Expenses)
-1.26-1.26-2.68-3.29-4.04-1.08
EBT Excluding Unusual Items
224.21185.46125.22122.5263.748.53
Gain (Loss) on Sale of Assets
-45.3-45.33.01---
Pretax Income
178.91140.16128.23122.5263.748.53
Income Tax Expense
29.3822.620.6817.7812.93-0.04
Net Income
149.53117.56107.55104.7550.7748.57
Net Income to Common
149.53117.56107.55104.7550.7748.57
Net Income Growth
2.35%9.31%2.68%106.34%4.52%20.48%
Shares Outstanding (Basic)
211815151515
Shares Outstanding (Diluted)
211815151515
Shares Change
39.63%18.94%1.86%--250.00%
EPS (Basic)
7.296.697.287.223.503.35
EPS (Diluted)
7.296.697.287.223.503.35
EPS Growth
-26.70%-8.10%0.83%106.29%4.51%-65.58%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-287.35-242.2872.76-12.1481.389.81
Free Cash Flow Per Share
-14.01-13.794.92-0.845.610.68
Dividend Per Share
---1.0003.1000.886
Dividend Growth
----67.74%250.01%-
Gross Margin
33.06%36.89%35.42%37.56%32.42%32.39%
Operating Margin
17.15%18.01%13.87%14.68%9.76%7.82%
Profit Margin
10.76%10.69%10.57%11.35%6.34%6.87%
Free Cash Flow Margin
-20.69%-22.02%7.15%-1.31%10.16%1.39%
EBITDA
248.65208.8150.11145.3688.3464.7
EBITDA Margin
17.90%18.98%14.75%15.75%11.03%9.15%
D&A For EBITDA
10.4510.6699.8710.179.4
EBIT
238.2198.14141.11135.4978.1755.3
EBIT Margin
17.15%18.01%13.87%14.68%9.76%7.82%
Effective Tax Rate
16.42%16.12%16.13%14.51%20.30%-
Revenue as Reported
1,3961,1071,023925.46801.94710.66
Advertising Expenses
-7.047.374.111.491.75